Insider Trading History of Morl Christopher John


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Morl Christopher John since year 2005. The trader's CIK number is 1716821. At the time of the last reporting, Morl Christopher John was the Chief Business Officer of Deciphera Pharmaceuticals, Inc. . (stock ticker symbol DCPH). See this page for all insider trading activities at Deciphera Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Morl Christopher John since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-01-16 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 3,011 3.95 11,893
2020-01-15 DCPH Deciphera Pharmaceuticals, Inc. Sale 12,023 65.23 784,272
2020-01-16 DCPH Deciphera Pharmaceuticals, Inc. Sale 3,011 65.40 196,931
2020-01-15 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 12,023 3.95 47,490
2020-01-07 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 1,650 3.95 6,517
2020-01-08 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 12,281 3.95 48,509
2020-01-07 DCPH Deciphera Pharmaceuticals, Inc. Sale 1,650 60.02 99,036
2020-01-08 DCPH Deciphera Pharmaceuticals, Inc. Sale 12,281 60.12 738,272
2020-01-02 DCPH Deciphera Pharmaceuticals, Inc. Sale 16,137 60.00 968,268
2020-01-02 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 16,137 3.95 63,741
2019-12-12 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 15,034 3.95 59,384
2019-12-12 DCPH Deciphera Pharmaceuticals, Inc. Sale 15,034 60.00 902,040
2019-12-09 DCPH Deciphera Pharmaceuticals, Inc. Sale 3,387 55.00 186,285
2019-12-10 DCPH Deciphera Pharmaceuticals, Inc. Sale 11,647 55.00 640,585
2019-12-09 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 3,387 3.95 13,378
2019-12-10 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 11,647 3.95 46,005
2019-12-03 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 15,034 .00 0
2019-12-03 DCPH Deciphera Pharmaceuticals, Inc. Sale 15,034 50.00 751,760

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Morl Christopher John (Chief Business Officer of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month